SPINT2 Is Associated with Dual-Phenotype Hepatocellular Carcinoma and Aggressive Tumor Features.
4 affiliations
- 1Department of Hepatobiliary Surgery, Guangxi Medical University Cancer Hospital, Nanning 530021, China.
- 2Guangxi Key Laboratory of Early Prevention and Treatment of Regional High Frequency Tumors, Nanning 530021, China.
- 3Division of Health Science, Graduate School of Health Science, Suzuka University of Medical Science, Suzuka 510-0293, Japan.
- 4School of Oncology, Guangxi Medical University, Nanning 530021, China.
Abstract
Background: Hepatocellular carcinoma (HCC) heterogeneity, particularly the presence of tumor cells co-expressing hepatocytic and cholangiocytic markers, contributes to therapeutic resistance and poor prognosis, yet its molecular correlates remain incompletely understood. This study aimed to characterize dual-phenotype HCC (DPHCC) and investigate the association and functional relevance of SPINT2 in tumor progression. Methods: We integrated multiplex immunofluorescence, CyTOF mass cytometry, single-cell RNA sequencing, and functional assays across clinical cohorts and cell lines. Results: Multiplex staining identified DPHCC in 22.89% of patients, correlating significantly with younger age, elevated AFP, and inferior recurrence-free and overall survival compared to non-DPHCC cases. Parallel scRNA-seq and CyTOF analyses showed that DPHCC-associated cells were enriched for stemness- and EMT-related features, with SPINT2 emerging as a top candidate gene in the transcriptomic analysis. Immunohistochemistry showed higher SPINT2 expression in DPHCC tissues, and high SPINT2 expression was associated with shorter overall survival in univariate Kaplan-Meier analysis and frequently co-localized with CK19. Functionally, SPINT2 modulation produced context-dependent changes in invasion, proliferation-related CCK-8 readouts, wound closure, sphere formation, and xenograft tumor growth in MHCC-97H and MHCC-LM3 cells. Collectively, these findings characterize DPHCC as a clinically relevant dual-lineage phenotypic state associated with aggressive tumor features and identify SPINT2 as a candidate molecule associated with this phenotype. Conclusions: SPINT2 is associated with the DPHCC-related state and aggressive tumor-cell phenotypes, but its mechanistic and clinical significance requires further validation.
Related
- Network perturbation of lactate metabolism identifies an aggressive hepatocellular carcinoma subtype with distinct immune and microbial features.
- Aggressive features and immune landscape of macrotrabecular hepatocellular carcinoma.
- Cancer-associated fibroblasts shape features of lymphocyte aggregation and collagen deposition in hepatocellular carcinoma
- ORC1 expression features and its prognostic significance in HBV-associated hepatocellular carcinoma
- Potential Influence of NUCB2 Genetic Variants on the Clinicopathological Features of Patients with Hepatocellular Carcinoma
BibTeX
@article{zhang2026spint2,
title = {{SPINT2 Is Associated with Dual-Phenotype Hepatocellular Carcinoma and Aggressive Tumor Features.}},
author = {Jie Zhang and Minjun Li and Taixin Yang and Ning Ma and Yaohong Liu and Chunye Fang and Chenglei Yang and Bangde Xiang},
journal = {Cancers},
year = {2026},
month = sep,
doi = {10.3390/cancers18193102},
url = {https://europepmc.org/article/MED/42882797},
note = {CC BY},
}
RIS
TY - JOUR
TI - SPINT2 Is Associated with Dual-Phenotype Hepatocellular Carcinoma and Aggressive Tumor Features.
AU - Jie Zhang
AU - Minjun Li
AU - Taixin Yang
AU - Ning Ma
AU - Yaohong Liu
AU - Chunye Fang
AU - Chenglei Yang
AU - Bangde Xiang
PY - 2026
DA - 2026/09/24
JO - Cancers
DO - 10.3390/cancers18193102
UR - https://europepmc.org/article/MED/42882797
AB - Background: Hepatocellular carcinoma (HCC) heterogeneity, particularly the presence of tumor cells co-expressing hepatocytic and cholangiocytic markers, contributes to therapeutic resistance and poor prognosis, yet its molecular correlates remain incompletely understood. This study aimed to characterize dual-phenotype HCC (DPHCC) and investigate the association and functional relevance of SPINT2 in tumor progression. Methods: We integrated multiplex immunofluorescence, CyTOF mass cytometry, single-cell RNA sequencing, and functional assays across clinical cohorts and cell lines. Results: Multiplex staining identified DPHCC in 22.89% of patients, correlating significantly with younger age, elevated AFP, and inferior recurrence-free and overall survival compared to non-DPHCC cases. Parallel scRNA-seq and CyTOF analyses showed that DPHCC-associated cells were enriched for stemness- and EMT-related features, with SPINT2 emerging as a top candidate gene in the transcriptomic analysis. Immunohistochemistry showed higher SPINT2 expression in DPHCC tissues, and high SPINT2 expression was associated with shorter overall survival in univariate Kaplan-Meier analysis and frequently co-localized with CK19. Functionally, SPINT2 modulation produced context-dependent changes in invasion, proliferation-related CCK-8 readouts, wound closure, sphere formation, and xenograft tumor growth in MHCC-97H and MHCC-LM3 cells. Collectively, these findings characterize DPHCC as a clinically relevant dual-lineage phenotypic state associated with aggressive tumor features and identify SPINT2 as a candidate molecule associated with this phenotype. Conclusions: SPINT2 is associated with the DPHCC-related state and aggressive tumor-cell phenotypes, but its mechanistic and clinical significance requires further validation.
SN - 2072-6694
ER -